What Researchers Did
Researchers reviewed the current understanding of *Helicobacter pylori* infection and summarized various non-drug treatments being explored to combat antibiotic resistance.
What They Found
The review outlined how *H. pylori* colonizes the stomach and causes disease, then detailed several non-pharmacological treatment methods. These included probiotics, oxygen-rich environments or hyperbaric oxygen therapy (HBOT), antibacterial photodynamic therapy, nanomaterials, antimicrobial peptides, phage therapy, and modified lysins. The study emphasized these approaches as potential new strategies to overcome the increasing antibiotic resistance in *H. pylori* treatment.
What This Means for Canadian Patients
*Helicobacter pylori* infection is a major cause of chronic gastritis and ulcers, and antibiotic resistance makes it increasingly difficult to treat. For Canadian patients struggling with persistent *H. pylori* infections, this review suggests that non-drug options like HBOT could offer promising new avenues for treatment, potentially improving health outcomes when standard antibiotics are no longer effective.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This review summarizes existing research on non-pharmacological therapies but does not present new experimental data on their effectiveness in treating *Helicobacter pylori*.